# Grifols signs 15-year immunoglobulin supply agreement with Canadian Blood Services

Grifols signed a 15-year agreement with Canadian Blood Services to manufacture immunoglobulin from Canadian plasma at its Montreal fractionation facility, aiming to increase Canada's Ig self-sufficiency from 15% to 50%. The deal includes an incremental 2.4 million grams of Ig annually.

- Type: Contract
- Announced: 2022-09-07
- Where: Montreal, Canada, Canada
- Status: announced
- Capacity: 2.4 million grams of Ig per year
- Products: immunoglobulin medicines

## Companies

- [Grifols](https://endata.com/companies/23767.md) (supplier)
- [Canadian Blood Services](https://endata.com/companies/65187.md) (customer)

## Sources

- [newswire.ca](https://www.newswire.ca/fr/news-releases/grifols-enters-into-agreement-with-canadian-blood-services-to-accelerate-self-sufficiency-in-immunoglobulins-for-canada-838807731.html), 2022-09-07: "It's the first-ever agreement of its kind and will ensure Canadian plasma is processed into Ig medicines on Canadian soil for the exclusive needs of the thousands of patients in the country."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.